| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > Outsourcing from Europe to Europe |
|
Digg It - Outsourcing from Europe to Europe
What is it? Outsourcing is the delegation of tasks or jobs from internal production to an external entity (such as a subco According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ntractor). Recently the term is being used for delegation to countries where salaries are very low in order to cut the costs. Stil ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in , most of the outsourcing that occurs today still occurs within the country boundaries. Why? Delegation to eastern countries can b lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ring several obstacles. Finding a reliable and suitable partner is a hard task. In order to benefit from outsourcing without a hug here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe risk you need reliable partner, company or individuals. Selection process is hard due to cultural differences such as completely d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ifferent education and people's skill set. Salaries are low in undeveloped countries where the market is undeveloped and the defin ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ition of an expert is different. Last but not least, despite the new age communication technology people still must have live meet easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ngs in certain situations which may be very expensive and takes time to organize. Buying services is necessarily considered outsou nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically cing. Outsourcing always involves a considerable degree of co-ordination and information exchange. Because of a high risk of orga and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ nizational problems, co-ordination and communicational obstacles (time zone difference brings many), lack of business understandin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi in eastern contries, cultural differences, physical distance, not enough trusted and reliable partners etc. many companies will n ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a t take the risk to outsource outside the country despite the big market pressure to do more for less. But some companies do take dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the risk because of the high potential. They mostly outsource the least connected to bussiness parts of the product cycle chain su cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin h as development. For small companies offshore development by freelances can cut costs but is not easy to manage and has many risk tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen . Eastern Europe Do you know that most IT projects don't fail because of IT reasons? The highest reason on the scale is t t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel he business understanding problem. Please check any study you wish to confirm that. Bringing new organizational risks might be muc ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust more dangerous then you think. On the other side, cutting costs has high potential. Is it possible to live with all those? We thi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products k it is, and that is the reason why we suggest outsourcing to Eastern Europe over outsourcing to India. Outsourcing to far East br . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ings many new risks: cultural barrier makes it harder to understand the business gols, time-zone difference makes it hard even to elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ake an online meeting. We suggest outsourcing to Eastern Europe. Last but not least, when you need a live meeting it's easy to fly tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Improve Patient Loyalty with Integrated Electronic Medical Billing, Notes, And Scheduling Software Job Seeking Advice For College Graduates Career Success with Contribution, Confidence, Creativity, Courage and Commitment
|